NovaBay Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
NovaBay Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
NovaBay Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
NovaBay Pharmaceuticals | 10-K/A: Annual report (Amendment)
NovaBay Pharmaceuticals | 10-K: FY2023 Annual Report
NovaBay Pharmaceuticals | 8-K: NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
NovaBay Pharmaceuticals | 10-Q: Q3 2023 Earnings Report
NovaBay Pharmaceuticals | 10-Q: Q2 2023 Earnings Report
NovaBay Pharmaceuticals | 10-Q: Q1 2023 Earnings Report
NovaBay Pharmaceuticals | 10-K/A: Annual report (Amendment)
NovaBay Pharmaceuticals | 10-K: FY2022 Annual Report
NovaBay Pharmaceuticals | 10-Q: Q3 2022 Earnings Report
NovaBay Pharmaceuticals | 10-Q: Q2 2022 Earnings Report
NovaBay Pharmaceuticals | 10-Q: Q1 2022 Earnings Report
NovaBay Pharmaceuticals | 10-K: FY2021 Annual Report
NovaBay Pharmaceuticals | 10-Q: Q3 2021 Earnings Report
NovaBay Pharmaceuticals | 10-Q: Q2 2021 Earnings Report
NovaBay Pharmaceuticals | 10-Q: Q1 2021 Earnings Report
NovaBay Pharmaceuticals | 10-K: FY2020 Annual Report
NovaBay Pharmaceuticals | 10-Q: Q3 2020 Earnings Report
No Data
No Data